SEC Form 4 · accession 0001104659-15-044671
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Walter Peltz
Officer — Chief Executive Officer · Director
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2015 | M | 60,306 | $10.85 | A | 60,306 | D | |
| Common Stock | Jun 8, 2015 | M | 17,170 | $10.85 | A | 77,476 | D | |
| Common StockF2 | Jun 8, 2015 | S | 11,825 | $53.81 | D | 65,651 | D | |
| Common StockF3 | Jun 8, 2015 | S | 36,075 | $54.64 | D | 29,576 | D | |
| Common StockF4 | Jun 8, 2015 | S | 22,300 | $55.71 | D | 7,276 | D | |
| Common StockF5 | Jun 8, 2015 | S | 3,500 | $56.40 | D | 3,776 | D | |
| Common Stock | Jun 9, 2015 | M | 26,300 | $10.85 | A | 30,076 | D | |
| Common StockF6 | Jun 9, 2015 | S | 12,500 | $52.89 | D | 17,576 | D | |
| Common StockF7 | Jun 9, 2015 | S | 13,400 | $53.64 | D | 4,176 | D | |
| Common StockF8 | Jun 9, 2015 | S | 400 | $54.29 | D | 3,776 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F9 | $10.85 | Jun 8, 2015 | M | 60,306 | D | — | May 15, 2023 | Common Stock | 60,306 | 110,694 | D |
| Stock Option (Right to Buy)F10 | $10.85 | Jun 8, 2015 | M | 17,170 | D | — | May 15, 2023 | Common Stock | 17,170 | 382,830 | D |
| Stock Option (Right to Buy)F10 | $10.85 | Jun 9, 2015 | M | 26,300 | D | — | May 15, 2023 | Common Stock | 26,300 | 356,530 | D |
| Stock Option (Right to Buy)F11 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 200,000 | 200,000 | D |
| Stock Option (Right to Buy)F12 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 300,000 | 300,000 | D |
| Stock Option (Right to Buy)F13 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 416 | 416 | D |
| Stock Option (Right to Buy)F14 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 541 | 541 | D |
| Stock Option (Right to Buy)F14 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 583 | 583 | D |
| Stock Option (Right to Buy)F14 | $451.20 | holding | — | — | — | — | May 15, 2019 | Common Stock | 583 | 583 | D |
| Stock Option (Right to Buy)F14 | $735.60 | holding | — | — | — | — | Apr 1, 2018 | Common Stock | 293 | 293 | D |
| Stock Option (Right to Buy)F14 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 708 | 708 | D |
| Stock Option (Right to Buy)F14 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 322 | 322 | D |
| Stock Option (Right to Buy)F14 | $392.40 | holding | — | — | — | — | Mar 1, 2016 | Common Stock | 136 | 136 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of diversification.
- F10This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- F11This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F12This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- F13This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013.
- F14Currently exercisable.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.26 to $54.25 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.26 to $55.18 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.26 to $56.12 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.26 to $56.59 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.23 to $53.21per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.23 to $54.22 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F8This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.25 to $54.30 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F9This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.